SEVELAMERCARBONATE Salmon Pharma 800 mg fl 180 pce
7680654010018
CH-65401
V03AE02
07.99.0.
Reimbursement limitations:
RENAGEL
Impossibilité d'atteindre un produit Calcium-Phosphate inférieur ou égal à 4.4 avec un chélateur du phosphate …
1 / 3
google
Details
- Product number
- 6540101
- CPT
- -
- Packaging group
- 180
- Unit
- Tablette(n)
- Composition
- sevelameri carbonas 800 mg, lactosum monohydricum 286.25 mg, silica colloidalis anhydrica, zinci stearas, Überzug: hypromellosum, monoglyceriderorum diacetylates, pro compresso obducto.
Articles (1)
Sevelamercarbonate Salmon Pharma, Filmtabletten
Filmtabletten
180
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
800.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
286.25 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 148.45
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/03/2019
Authorization holder
Salmon Pharma GmbH
4052 Basel
Authorization information
- Swissmedic authorization number
- 65401
- Drug name
- Sevelamercarbonate Salmon Pharma, Filmtabletten
- Galenic form
- FILM
- ATC Code
- V03AE02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/10/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SEVELAMERCARBONATE Salmon Pharma 800 mg fl 180 pce
- Description (DE)
- SEVELAMERCARBONATE Salmon Pharma 800 mg Fl 180 Stk
- Market launch
- 26/10/2015
- Narcotic (BTM)
- No